CT053

· CARsgen Therapeutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CT053, covering 2024-03-12 to 2024-03-12. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial to Evaluate CT053 in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 1) [Phase 1, Phase 2]

See pricing